Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net earnings $ 338 $ 132
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 104 86
Stock compensation expense 33 32
Deferred income taxes 30 (51)
Changes in assets and liabilities    
Premium and trade receivables (176) 59
Other assets 51 89
Medical claims liabilities 485 358
Unearned revenue 317 320
Accounts payable and accrued expenses 157 (237)
Other long-term liabilities 477 459
Other operating activities, net 30 1
Net cash provided by operating activities 1,846 1,248
Cash flows from investing activities:    
Capital expenditures (218) (83)
Purchases of investments (765) (582)
Sales and maturities of investments 445 343
Acquisitions, net of cash acquired (226) 0
Other investing activities, net 0 (1)
Net cash used in investing activities (764) (323)
Cash flows from financing activities:    
Proceeds from long-term debt 2,015 560
Payments of long-term debt (1,491) (560)
Common stock repurchases (9) (13)
Other financing activities, net (2) 3
Net cash provided by (used in) financing activities 513 (10)
Net increase in cash, cash equivalents and restricted cash 1,595 915
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period 4,089 3,936
Cash, cash equivalents, and restricted cash and cash equivalents, end of period 5,684 4,851
Supplemental disclosures of cash flow information:    
Interest paid 73 72
Income taxes paid 1 2
Equity issued in connection with acquisitions $ 324 $ 0